Sugammadex hypersensitivity-A case of anaphylaxis

Anaesthesia and Intensive Care

Volumn 42, Issue 1, 2014, Pages 89-92

  Jeyadoss, J ^a   Kuruppu, P ^a   Nanjappa, N ^a   Van Wijk, R M ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Anaphylaxis; Sugammadex

Indexed keywords

ADRENALIN; CEFAZOLIN; DESFLURANE; DEXAMETHASONE; DROPERIDOL; FENTANYL; GELATIN; GRANISETRON; HEPARIN; PROPOFOL; ROCURONIUM; ROPIVACAINE; SUGAMMADEX; TRYPTASE;

ABDOMINAL AORTA ANEURYSM; ADULT; AIRWAY PRESSURE; ALLERGY TEST; ANESTHESIA INDUCTION; ANEURYSM SURGERY; AORTA CLAMPING; AORTOFEMORAL BYPASS; ARTERIAL LINE; ARTICLE; BLOOD PRESSURE; CASE REPORT; CENTRAL VENOUS PRESSURE; COMORBIDITY; CONTINUOUS INFUSION; CRYSTALLOID; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; ENDOTRACHEAL INTUBATION; EPIDURAL CATHETER; FLUID RESUSCITATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGED; OPERATIVE BLOOD LOSS; OXYGEN THERAPY; PULSE PRESSURE; REPEATED DRUG DOSE; RESUSCITATION; SHOCK; TACHYCARDIA; THORAX EPIDURAL ANESTHESIA; URTICARIA;

EID: 84893823190     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1404200115     Document Type: Article

References (14)

1. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. Eur J Anaesthesiol 2010; 27:874-881.
2. de Menezes CC, Peceguini LA, Silva ED, Simões CM. Use of sugammadex after neostigmine incomplete reversaLof rocuronium- induced neuromuscular blockade. Rev Bras AnestesioL2012; 62:543-547.
3. Pavoni V, Gianesello L, De Scisciolo G, Provvedi E, Horton D, Barbagli R et al. Reversal of profound and "deep" residuaLrocuronium-induced neuromuscular blockade by sugammadex: a neurophysiologicaLstudy. Minerva AnestesioL2012; 78:542-549.
4. Ledowski T, Hillyard S, Kozman A, Johnston F, Gillies E, Greenaway M et al. Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice and associated healthcare costs. Anaesth Intensive Care 2012; 40:340-343.
5. Watts RW, London JA, van Wijk RM, Lui YL. The influence of unrestricted use of sugammadex on clinical anaesthetic practice in a tertiary teaching hospital. Anaesth Intensive Care 2012; 40:333-339.
6. Dahl V, Pendeville PE, Hollmann MW, Heier T, Abels EA, Blobner M. Safety and efficacy of sugammadex for the reversaLof rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. Eur J Anaesthesiol 2009; 26:874-884.
7. McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB et al. Efficacy, safety, and pharmacokinetics of sugammadex for the reversaLof rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology 2011; 114:318-329.
8. Naguib M, BrulLSorin J. Update on neuromuscular pharmacology. Curr Opin Anaesthesiol 2009; 22:483-490.
9. G odai K, Hasegawa-Moriyama M, Kuniyoshi T, Kakoi T, Ikoma K, Isowaki S et al. Three cases of suspected sugammadex- induced hypersensitivity reactions. Br J Anaesth 2012; 109:216-218.
10. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ. Allergy to low dose sugammadex. Anaesthesia 2011; 66:217-219.
11. Florvaag E, Johansson SG, Oman H, Venemalm L, Degerbeck F, Dybendal T et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005; 49:437-444.
12. Ewan PW, Dugue P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2010; 40:15-31.
13. Fisher MM, Bowey CJ. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 1997; 79:59-63.
14. G ibbs NM, Sadleir PH, Clarke RC, Platt PR. Survival from perioperative anaphylaxis in Western Australia 2000-2009. Br J Anaesth 2013; 111:589-593.